Feasibility of an Enhanced Symptom Monitoring and Expedited Subspecialty Care Referral Intervention to Improve Side Effect Management for Patients With Melanoma Receiving an Immune Checkpoint Inhibitor

NCT07660666 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Melanoma

Interventions

OTHER: Electronic Health Record Review
OTHER: Internet-Based Intervention
BEHAVIORAL: Patient Navigation
OTHER: Survey Administration
OTHER: Survey Administration

Sponsor

OHSU Knight Cancer Institute